Cytokines such as IL22 or proteins like R‐spondin‐1 showed success in preventing dysbiosis and improving PC status in in vivo models of GVHD (Takashima et al, 2011; Hanash et al, 2013; Hayase et al, 2017). Here, IL22 is linked to graft versus host disease.